Prestige Consumer Healthcare (NYSE:PBH) Announces Earnings Results, Meets Estimates

Prestige Consumer Healthcare (NYSE:PBH) released its quarterly earnings data on Thursday. The company reported $1.09 earnings per share for the quarter, hitting the consensus estimate of $1.09, Briefing.com reports. The business had revenue of $283.79 million during the quarter, compared to analysts’ expectations of $282.09 million. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The business’s revenue was down .9% on a year-over-year basis. During the same quarter last year, the business posted $1.07 EPS. Prestige Consumer Healthcare updated its FY 2025 guidance to 4.460-4.460 EPS and its FY25 guidance to $4.40 to $4.46 EPS.

Prestige Consumer Healthcare Trading Up 0.3 %

NYSE:PBH opened at $80.37 on Friday. Prestige Consumer Healthcare has a one year low of $56.61 and a one year high of $81.25. The company’s 50-day simple moving average is $72.55 and its 200 day simple moving average is $69.84. The firm has a market capitalization of $3.98 billion, a P/E ratio of 19.55, a PEG ratio of 2.19 and a beta of 0.47. The company has a debt-to-equity ratio of 0.65, a current ratio of 3.23 and a quick ratio of 1.90.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the stock. Jefferies Financial Group reiterated a “hold” rating and issued a $76.00 price target (up previously from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. DA Davidson lifted their price objective on Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Wednesday, August 28th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $94.20.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.